Castle Biosciences Unveils Key Data on TissueCypher at ACG
New Insights from Castle Biosciences at Annual Meeting Castle Biosciences, Inc. (NASDAQ: CSTL) recently highlighted groundbreaking research at a prestigious conference, showcasing its innovative TissueCypher Barrett's Esophagus test. This test provides critical risk insights that go beyond traditional pathology, influencing clinical management for early intervention in...
Continue Reading